Jennifer Fitzpatrick serves as Executive at Sionna Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Jennifer Fitzpatrick has executed 4 insider transactions totaling $652.3K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 5, 2025 involved exercising options for 10,250 shares valued at $62.6K.
Jennifer Fitzpatrick currently holds 10,250 shares of Sionna Therapeutics, Inc. (SION), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jennifer Fitzpatrick has been a net seller of SION stock. They have purchased $0 and sold $652.3K worth of shares.
Jennifer Fitzpatrick's most recent insider trade was on Dec 5, 2025, when they sold 10,250 shares at $6.11 per share.
Get notified when new Form 4 filings are submitted
| $40.52 |
| Discretionary |
| Sep 4, 2025 | SION | $62.6K | Option Exercise | 10,250 | $6.11 | Discretionary |
| Sep 4, 2025 | SION | $237.0K | Sale | 10,250 | $23.12 | Discretionary |